Balchem Corporation Business Acquisition, Pro Forma Revenue
Balchem Corporation (BCPC) reported Business Acquisition, Pro Forma Revenue of $922.44 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-02-21.
Financial Statements › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2025-02-21
- Balchem Corporation business acquisition, pro forma revenue for the quarter ending 2023-12-31 was $228.70M, a 1.65% decline year-over-year.
- Balchem Corporation business acquisition, pro forma revenue for the quarter ending 2023-09-30 was $229.95M, a 7.13% decline year-over-year.
- Balchem Corporation business acquisition, pro forma revenue for the quarter ending 2023-06-30 was $231.25M, a 9.14% decline year-over-year.
- Balchem Corporation business acquisition, pro forma revenue for the quarter ending 2023-03-31 was $232.54M, a 5.99% decline year-over-year.
- Balchem Corporation business acquisition, pro forma revenue for fiscal 2023 was $922.44M, a 6.07% decline from fiscal 2022.
- Balchem Corporation business acquisition, pro forma revenue for fiscal 2022 was $982.02M, a 14.29% increase from fiscal 2021.
- Balchem Corporation business acquisition, pro forma revenue for fiscal 2021 was $859.25M.
- Balchem Corporation business acquisition, pro forma revenue for fiscal 2017 was $594.79M, a 6.63% increase from fiscal 2016.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 3 month as first filed | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 6 month as first filed | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 9 month as first filed | Business Acquisition, Pro Forma Revenue 12 month | Business Acquisition, Pro Forma Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | $228.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $458.65M derived: sum of 2 quarters · filed 2025-02-21 | $689.90M derived: sum of 3 quarters · filed 2025-02-21 | $922.44M 10-K · filed 2025-02-21 | ||||
| 2023-09-30 | $229.95M 10-Q · filed 2023-10-27 | $461.20M derived: sum of 2 quarters · filed 2023-10-27 | $693.74M 10-Q · filed 2023-10-27 | $926.27M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-06-30 | $231.25M 10-Q · filed 2023-07-28 | $463.79M 10-Q · filed 2023-07-28 | $696.32M derived: sum of 3 quarters · filed 2025-02-21 | $943.94M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-03-31 | $232.54M 10-Q · filed 2023-04-28 | $465.07M derived: sum of 2 quarters · filed 2025-02-21 | $712.69M derived: sum of 3 quarters · filed 2025-02-21 | $967.19M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2022-12-31 | $232.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $480.15M derived: sum of 2 quarters · filed 2025-02-21 | $734.65M derived: sum of 3 quarters · filed 2025-02-21 | $982.02M 10-K · filed 2025-02-21 | ||||
| 2022-09-30 | $247.61M 10-Q · filed 2023-10-27 | $502.12M derived: sum of 2 quarters · filed 2023-10-27 | $749.49M 10-Q · filed 2023-10-27 | |||||
| 2022-06-30 | $254.51M 10-Q · filed 2023-07-28 | $501.88M 10-Q · filed 2023-07-28 | ||||||
| 2022-03-31 | $247.37M 10-Q · filed 2023-04-28 | |||||||
| 2021-12-31 | $859.25M 10-K · filed 2025-02-21 | |||||||
| 2017-12-31 | $159.26M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $309.98M derived: sum of 2 quarters · filed 2018-03-01 | $457.06M derived: sum of 3 quarters · filed 2018-03-01 | $594.79M 10-K · filed 2018-03-01 | ||||
| 2017-09-30 | $150.72M 10-Q · filed 2017-11-07 | $297.80M derived: sum of 2 quarters · filed 2017-11-07 | $435.53M 10-Q · filed 2017-11-07 | $576.29M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2017-06-30 | $147.08M 10-Q · filed 2017-08-04 | $284.81M 10-Q · filed 2017-08-04 | $425.57M derived: sum of 3 quarters · filed 2018-03-01 | $564.08M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2017-03-31 | $137.73M 10-Q · filed 2017-05-09 | $278.49M derived: sum of 2 quarters · filed 2018-03-01 | $417.00M derived: sum of 3 quarters · filed 2018-03-01 | $555.79M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-12-31 | $140.76M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $279.27M derived: sum of 2 quarters · filed 2018-03-01 | $418.06M derived: sum of 3 quarters · filed 2018-03-01 | $557.78M 10-K · filed 2018-03-01 | ||||
| 2016-09-30 | $138.51M 10-Q · filed 2017-11-07 | $277.30M derived: sum of 2 quarters · filed 2017-11-07 | $417.02M 10-Q · filed 2017-11-07 | $559.36M derived: sum of 4 quarters · filed 2017-11-07 | ||||
| 2016-06-30 | $138.79M 10-Q · filed 2017-08-04 | $278.51M 10-Q · filed 2017-08-04 | $420.85M derived: sum of 3 quarters · filed 2017-08-04 | $573.82M derived: sum of 4 quarters · filed 2017-08-04 | ||||
| 2016-03-31 | $139.72M 10-Q · filed 2017-05-09 | $282.05M derived: sum of 2 quarters · filed 2017-05-09 | $435.02M derived: sum of 3 quarters · filed 2017-05-09 | $585.65M derived: sum of 4 quarters · filed 2017-05-09 | ||||
| 2015-12-31 | $142.33M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $295.30M derived: sum of 2 quarters · filed 2017-02-28 | $445.93M derived: sum of 3 quarters · filed 2017-02-28 | $605.27M 10-K · filed 2017-02-28 | $552.49M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | $152.97M 10-Q · filed 2016-11-04 | $140.13M 10-Q · filed 2015-11-04 | $303.59M derived: sum of 2 quarters · filed 2016-11-04 | $462.94M 10-Q · filed 2016-11-04 | $419.76M 10-Q · filed 2015-11-04 | $625.61M derived: sum of 4 quarters · filed 2016-11-04 | ||
| 2015-06-30 | $150.63M 10-Q · filed 2016-08-05 | $134.77M 10-Q · filed 2015-08-05 | $309.97M 10-Q · filed 2016-08-05 | $279.63M 10-Q · filed 2015-08-05 | $472.64M derived: sum of 3 quarters · filed 2016-08-05 | $633.13M derived: sum of 4 quarters · filed 2016-08-05 | ||
| 2015-03-31 | $159.35M 10-Q · filed 2016-05-10 | $144.86M 10-Q · filed 2015-05-07 | $322.02M derived: sum of 2 quarters · filed 2016-05-10 | $482.51M derived: sum of 3 quarters · filed 2016-05-10 | $640.14M derived: sum of 4 quarters · filed 2016-05-10 | |||
| 2014-12-31 | $162.67M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $323.16M derived: sum of 2 quarters · filed 2016-02-29 | $480.79M derived: sum of 3 quarters · filed 2016-02-29 | $625.40M 10-K · filed 2016-02-29 | ||||
| 2014-09-30 | $160.49M 10-Q · filed 2015-11-04 | $318.13M derived: sum of 2 quarters · filed 2015-11-04 | $462.73M 10-Q · filed 2015-11-04 | |||||
| 2014-06-30 | $157.63M 10-Q · filed 2015-08-05 | $302.24M 10-Q · filed 2015-08-05 | ||||||
| 2014-03-31 | $144.61M 10-Q · filed 2015-05-07 | |||||||
| 2013-12-31 | $545.59M 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Perimeter Solutions, Inc. (PRM) | $4.593B | -17.21 | |
| Ingevity Corp (NGVT) | United States | $2.468B | 47.72 |
| INNOSPEC INC. (IOSP) | United States | $2.380B | 16.37 |
| Chemours Co (CC) | United States | $2.136B | -10.64 |
| OLIN Corp (OLN) | United States | $1.852B | -11.54 |
| Solstice Advanced Materials Inc. (SOLS) | United States | $8.905B | 67.02 |
| Huntsman CORP (HUN) | United States | $1.540B | -6.95 |
| FMC CORP (FMC) | United States | $1.201B | -0.52 |
| Ecovyst Inc. (ECVT) | United States | $1.110B | -22.22 |
| ASCENT INDUSTRIES CO. (ACNT) | United States | $0.132B | -30.55 |